Eliscription Private Limited - Company Profile

It is a business outsourcing private limited company based in Hyderabad, Telangana, India, established in 2013.
2013 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Eliscription Private Limited

Eliscription Private Limited, a active private limited company, was established on 26 March 2013 in Hyderabad, Telangana, India. Engaging in medical transcription within the information and communication sector, it holds CIN: U74900TG2013PTC086622. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 1 professional, Its leadership includes Sri Kanth Kasala (Ceo), Vanitha Datla (Director), Ramesh Datla (Director). It holds ₹6.43 Cr open charges and ₹5.31 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-91, Apie,Sanathnagar, Industrialestate Extension, Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900TG2013PTC086622

  • Registration Number

    086622

  • Incorporation Date

    26 March 2013

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.43 Cr
  • Satisfied Charges ₹ 5.31 Cr
  • Revenue Growth **** 2.44%
  • Profit Growth **** -9.18%
  • Ebitda **** -35.61%
  • Net Worth -81.11%
  • Total Assets **** 27.27%
Company report

Eliscription Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eliscription Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eliscription Private Limited?
Current Directors
Name Designation Appointment Date Status
Sri Kanth Kasala Ceo 01 Jan 2021 Current
Vanitha Datla Director 26 Mar 2013 Current
Ramesh Datla Director 26 Mar 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eliscription.

Eliscription Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.44% increase. The company also saw a slight decrease in profitability, with a 9.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 81.11%.

Eliscription revenue growth over time
Eliscription profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.44%
*******
*******
*******
*******
Revenue from Operations
*******
 1.00%
*******
*******
*******
*******
Total Assets
*******
 27.27%
*******
*******
*******
*******
Profit or Loss
*******
 -9.18%
*******
*******
*******
*******
Net Worth
*******
 -81.11%
*******
*******
*******
*******
EBITDA
*******
 -35.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eliscription?

In 2023, Eliscription had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹64,300,000.00

Satisfied Charges

₹53,092,647.00

Charges Breakdown by Lending Institutions
  • Others : 6.43 Cr
Latest Charge Details
Date Lender Amount Status
31 Mar 2022 Others ₹1.43 Cr Open
31 Mar 2021 Others ₹2.50 Cr Open
24 Jun 2020 Others ₹2.50 Cr Open
30 Sep 2021 Axis Bank Limited ₹5.59 M Satisfied
15 Feb 2019 Axis Bank Limited ₹6.40 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Eliscription?

Eliscription has a workforce of 1 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eliscription, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eliscription's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eliscription
Recent Activity within the Organization
  • Annual General Meeting

    Eliscription Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge registered on 01 Sep 2018 via Charge ID 100200086 with Others was fully satisfied on 04 Sep 2024. was completed.

  • Balance Sheet

    Progress on Eliscription Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Charges

    A charge registered on 30 Sep 2021 via Charge ID 100505725 with Axis Bank Limited was fully satisfied on 04 Apr 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 14.30 M registered on 31 Mar 2022 with Charge ID 100561560 was modified on 21 Mar 2023. was documented.

  • Charges

    A charge with Others of Rs. 25.00 M registered on 31 Mar 2021 with Charge ID 100435301 was modified on 21 Mar 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eliscription Private Limited?

The CIN of Eliscription Private Limited is U74900TG2013PTC086622.

Where is Eliscription Private Limited headquartered?

Eliscription Private Limited is headquartered at B-91, Apie,Sanathnagar, Industrialestate Extension, Hyderabad, Telangana, 500018.

When was Eliscription Private Limited incorporated?

Eliscription Private Limited was incorporated on 26 March 2013.

Who are the current directors of Eliscription Private Limited?

The current directors of Eliscription Private Limited are

What is the primary industry of Eliscription Private Limited?

The primary industry of Eliscription Private Limited is Information And Communication.

Is Eliscription Private Limited a listed company?

Eliscription Private Limited is unlisted.

What is the capital structure of Eliscription Private Limited?

The authorized capital of Eliscription Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Eliscription Private Limited?

The compliance status of Eliscription Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available